Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kristin Baecher"'
Autor:
Amod A. Sarnaik, Young-Chul Kim, Michael C. Lowe, Giorgos C. Karakousis, James Sun, Emma H. A. Stahlie, Alexander C.J. van Akkooi, Kristin Baecher, David W. Ollila, Frances A. Collichio, Jonathan S. Zager, Syeda Mahrukh Hussnain Naqvi, Luke D. Rothermel, Richard J. Straker, G. Paul Wright, Danielle DePalo, Michael J Carr, Yun Song, Keith A. Delman, Raphael J. Louie
Publikováno v:
Annals of Surgical Oncology. 29:791-801
Talimogene laherparepvec (T-VEC) is an oncolytic virus approved for the treatment of unresectable, recurrent melanoma. The role of T-VEC after progression on systemic immunotherapy (IO) remains undefined. The goal of this study was to characterize th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5ee131299c2a7c78e5270e401a4d0c9
https://doi.org/10.1245/s10434-021-10910-5
https://doi.org/10.1245/s10434-021-10910-5
Autor:
Syeda Mahrukh Hussnain Naqvi, Young-Chul Kim, Alexander C.J. van Akkooi, Michael C. Lowe, Yun Song, Frances A. Collichio, David W. Ollila, Richard J. Straker, Keith A. Delman, Jonathan S. Zager, Kristin Baecher, Danielle DePalo, Michael J Carr, Luke D. Rothermel, Emma H. A. Stahlie, Amod A. Sarnaik, Raphael J. Louie, James Sun, Giorgos C. Karakousis, G. Paul Wright
Publikováno v:
Annals of Surgical Oncology. 29:804-805
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6220e15525462fac9079ab030e505dfb
https://doi.org/10.1245/s10434-021-11036-4
https://doi.org/10.1245/s10434-021-11036-4
Autor:
Michael J, Carr, James, Sun, Danielle, DePalo, Luke D, Rothermel, Yun, Song, Richard J, Straker, Kristin, Baecher, Raphael J, Louie, Emma H A, Stahlie, G Paul, Wright, Syeda Mahrukh Hussnain, Naqvi, Youngchul, Kim, Amod A, Sarnaik, Giorgos C, Karakousis, Michael C, Lowe, Keith A, Delman, Alexander C J, van Akkooi, David W, Ollila, Frances, Collichio, Jonathan S, Zager
Publikováno v:
Annals of surgical oncology. 29(2)
Talimogene laherparepvec (T-VEC) is an oncolytic virus approved for the treatment of unresectable, recurrent melanoma. The role of T-VEC after progression on systemic immunotherapy (IO) remains undefined. The goal of this study was to characterize th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f66a3b07ef01afde8aac6d57a31bf9c
https://pubmed.ncbi.nlm.nih.gov/34648098
https://pubmed.ncbi.nlm.nih.gov/34648098